Regeneron Study Site — ‘Aiea, Hawaii

Regeneron Study Site is a clinical research site located in ‘Aiea, Hawaii, United States 96701.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Regeneron Study Site has participated in 1 clinical trials.

Therapeutic areas: Diabetic Macular Edema, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus.

Sponsors: Regeneron Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in ‘Aiea

Browse all research sites in Hawaii · View every site in ‘Aiea

• Pali Momi Medical Center
• The Cancer Center of Hawaii-Pali Momi
• Hawaii Cancer Care - Westridge
• Queen's Cancer Center - Pearlridge
• Kapiolani Medical Center at Pali Momi
• Hawaii Oncology Inc-Pali Momi
• Hawaii Cancer Care - Savio
• Oncare Hawaii Inc-Pali Momi
• Straub Pearlridge Clinic
• Retina Consultants of Hawaii
• Retina Consultants of Hawaii, Inc
• Pfizer Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Regeneron Study Site?

Regeneron Study Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Regeneron Study Site conducted?

Regeneron Study Site has 1 clinical trials on record. Their work covers Diabetic Macular Edema, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus.

Is Regeneron Study Site accredited by Crixeo Clinical Trials?

Regeneron Study Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Regeneron Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.